BCI
WST icon

Blue Capital Inc’s West Pharmaceutical WST Stock Holding History

Blue Capital Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401K Buy
+1,118
New +$342K 0.25% 78

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Blue Capital Inc's WST Position: Q2 2026 in Review

Blue Capital Inc opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,118 shares worth $401K. The stake represents 0.25% of the portfolio and ranks #78 among its holdings.

830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Blue Capital Inc held 1,118 shares of West Pharmaceutical worth $401K as of Q2 2026.
  • West Pharmaceutical was a new Blue Capital Inc position in Q2 2026.
  • West Pharmaceutical made up 0.25% of Blue Capital Inc's portfolio in Q2 2026, its #78 holding.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Blue Capital Inc's 13F filing for Q2 2026, filed 11 Aug 2026.